The 4th China International Import Expo (abbreviated as“China International Import Expo”）opened today at the National Exhibition and Convention Center (Shanghai), with globally leading life science company Bayer participating for the fourth consecutive year. Upholding“Sharing Health, Fighting Hunger”...’s corporate vision, Bayer showcased its three business divisions: Pharmaceuticals, Consumer Health, and Crop Science. Focusing on the five key needs of the Chinese people in their pursuit of a healthy and better life,——“Diet, Care, Prevention, Diagnosis, Treatment”，Bayer will fully leverage the platform effect of the CIIE to showcase its innovative achievements in healthcare and agricultural science, host a series of high-profile events, fulfill its long-term commitment to China, deepen its strategic layout for future development, and comprehensively support the Chinese people in realizing their vision of a healthy and better life.
“China has consistently been one of Bayer's most important markets. Looking at our nearly...140Over the years, we have consistently collaborated with China to address current and future challenges with innovative solutions.——Addressing population aging, ensuring food security, and meeting growing healthcare needs to create a better future.”Werner, Chairman of the Board of Management of Bayer Group·B. Braun (Werner Baumann) indicates,“As an international platform for sharing, exchange, and cooperation, the CIIE presents unmissable opportunities for multinational enterprises like Bayer. We aim to leverage the CIIE as an opportunity to strengthen innovation, deepen cooperation, and benefit more Chinese patients, consumers, and growers.”
Leveraging the CIIE Platform Advantage to Sound the Call for Innovation
The China International Import Expo (CIIE) provides an exceptional platform for multinational enterprises, including Bayer, to fully showcase their innovation capabilities and advanced technologies. At this edition, Bayer will highlight its healthcare innovations spanning oncology treatments, diabetes management, cardiovascular health, cell and gene therapies, and precision diagnostics. Concurrently, the company will present self-care solutions covering nutrition, digestive health, scalp health, and allergy relief, alongside leading agricultural innovations and localized sustainable development practices.
In the prescription drug sector, prostate cancer therapeuticsNubeqa®(Darolutamide)As an oral androgen receptor inhibitor (ARi), features a unique molecular structure and high receptor affinity, thereby inhibiting receptor function and the growth of prostate cancer cells. Nubeqa received marketing approval in China this year for the treatment of patients with non-metastatic castration-resistant prostate cancer at high risk of metastasis.
As a wearable device provided by Bayer for diabetic patients in China“Cutting-edge Technology”Equipment,Bayer Continuous Glucose Monitoring System (CGMs) By providing minute-by-minute continuous interstitial fluid glucose data, it serves as a basis for patients' self-management of blood glucose and for clinicians' decision-making regarding treatment regimens. The system was recently approved for clinical use in the Hainan Boao Lecheng Pilot Zone, marking the official launch of Bayer's innovative model for intelligent, comprehensive diabetes management.
At the CIIE venue, Bayer will also showcaseCell and Gene Therapy Fieldbreakthrough and innovative advancements, encompassing leading assets at various stages of clinical development. These R&D programs target multiple therapeutic areas with significant unmet medical needs, such as neurodegenerative diseases including Parkinson's disease, cardiovascular diseases, and rare diseases like Pompe disease.
In the consumer health sector, addressing consumers' increasingly quality-driven, diversified, and specialized health needs, Bayer will showcase a series of innovative, high-quality, and scientifically proven consumer health products.“Star”One of the exhibits was introduced via a cross-border e-commerce platform.Globally Renowned Multivitamin BrandOne A Day® Newly launched multivitamin fruit cubes,Derived from natural, real fruit pulp, the product is rich in ten core nutrients and offers customized formulations tailored to different demographics (men, women, and children), meeting the nutritional needs of the entire family.
In the field of crop science, local initiatives across Bayer's three core business areas—Crop Protection, Seeds, and Digital Farming—are fully showcased, leading the agricultural transformation and building a more sustainable food system. With nearly100Building on its crop protection products, Bayer has officially launched its first innovative amino acid-based biostimulant, Anbishen, in the Chinese market.®, further highlighting Bayer“Comprehensive Crop Health”Business Philosophy——Eco-friendly, healthy, high-quality, and efficient. This product fully unlocks the growth potential of crops, promoting vigorous growth, robust vitality, strong stress tolerance, and high yields. It helps farmers achieve increased production and bumper harvests, while safeguarding soil health and ensuring high-quality produce for consumers' tables. Meanwhile, Bayer is committed to enriching the "rice bags" and "vegetable baskets" of Chinese households, introducing DEKALB corn, tomatoes, broccoli, bell peppers, and more.High-Quality Crop Varieties. Additionally, the Bayer booth will also showcaseIndustry-Leading One-Stop Service Platform for Growers“Yuenongtang”andDigital Agricultural Services China Pilot ProjectPlantect®And Other Localized Digital Agriculture Practices in China, outlining a digitally empowered modern agricultural ecosystem of the future.
Deepen CIIE Engagement“Spillover effect”, promote“Dual Circulation”Developing a New Landscape, Expanding Local Collaboration
The China International Import Expo (CIIE) is China's practice of“Dual Circulation”As one of the key platforms for strategic initiatives and promoting international exchanges, it has continuously driven the accelerated pace and robust momentum of collaboration between domestic and global innovation forces over the past four years. By further expanding engagement channels with government bodies, industry partners, and consumers, Bayer is firmly capitalizing on development opportunities in China. The company continues to deepen multi-sector collaboration with local partners to meticulously develop more innovative products and solutions tailored to local needs for patients, consumers, and growers in China.
For example, specifically developed for Chinese consumersDaYiXi®, is a probiotic product jointly launched by Bayer, Jiangnan University, and VProbiotics. Based on the dietary habits of Chinese consumers and adhering to pharmaceutical-grade standards, it rigorously selects patented indigenous strains derived from the Chinese gut environment from a library of over 10,000 strains, to precisely modulate the gut health of the Chinese population. Dayixi®...successful launch, vividly demonstrates how the CIIE helps facilitate the transition from“Establish Partnership”to“Exhibit Setup”then to“Product Launch”of“Spillover effect”, empowering Bayer and its local partners to leverage their respective strengths and achieve win-win collaboration, thereby providing more customized health solutions for Chinese consumers.
Over the coming days, the Bayer booth willFour Major Theme Days: Healthcare Day, Crop Science Day, Imaging & Diagnostics Day, and Public Health DayActing as a guide, it will feature a series of major signing ceremonies with government and local partners. For example, Bayer plans to collaborate with the Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration, the Chinese County Hospital Presidents Alliance, Jointown, Hangzhou Qiantang District, Benlai.com, and others, to comprehensively deepen Bayer’s footprint in China and help China build“Dual Circulation”New Development Paradigm.
Based on national development plans, advancing towards“Common Prosperity”New Era
In the country“14th Five-Year Plan”Under the guidance of the plan, Bayer continuously leverages its strengths in the healthcare and agricultural science sectors, actively promotes healthcare accessibility, extends its reach to grassroots county-level areas, and through concrete actions, to“Healthy China”and“Rural Revitalization”Contributing Our Share, Building Together“Common Prosperity”of a better future.
Focused on enhancing high-quality, refined medical and healthcare services, Bayer has organized a series of booth events at this CIIE, including the unveiling of the feature-length medical documentary “Life of Light and Shadow,” and activities centered around “Starting from the Head” expert discussions centered on the popular science book 《Discovering Health》 on hair and scalp health, and the launch of“Prostate Cancer Patient Care Month”Special events and interactive women's health education activities, among others, effectively embody the patient- and consumer-centric philosophy, making healthcare services more compassionate and warm.
Meanwhile, in response to the pressing healthcare needs across China's vast county-level regions, Bayer actively promotes the coverage and integration of innovative smart healthcare practices at the primary care level, helping to improve the current grassroots healthcare landscape marked by high patient volumes, physician shortages, and elevated training costs. Exhibited at this event,Stellant D-CE, is China's first intelligent and digitalCTThe high-pressure injection system provides personalized contrast media injection protocols tailored to patients, improving examination success rates, delivering clearer medical images, and helping primary healthcare professionals and patients achieve more accurate diagnoses. Recently, Bayer MedradStellant D-CE P3Talso received the ... hosted by the China County Hospital Presidents Alliance“2021Call for Typical Cases of Informatization and Big Data in County-Level Hospitals——County-Level Pioneer Smart Solution”Grand Award, empowering the digital transformation and upgrading of radiology departments in county-level hospitals, for“Empowering Primary Healthcare”Make a contribution.
In promoting rural revitalization and achieving“Common Prosperity”In the process of, Bayer actively responds to national authorities 《“14th Five-Year Plan”National Agricultural Green Development Plan》，assisting in promoting the comprehensive green transition of China's agricultural development. During the China International Import Expo, Bayer Crop Science will sign an investment letter of intent with Qiantang District, Hangzhou, with plans to construct a new facility in Hangzhou to further meet the demand in China and the Asia-Pacific markets for innovative, highly efficient, and green crop protection products, thereby contributing to China's efforts to enhance the resilience of the global agrochemical supply chain.
Next year will mark the ... anniversary of Bayer's partnership with China.140anniversary, which also coincides with the establishment of diplomatic relations between China and Germany50anniversary. As one of the earliest multinational corporations to enter the Chinese market, Bayer's confidence and determination to take root and grow in China remain unwavering. Bayer has already signed the agreement and secured a booth for the 5th China International Import Expo (CIIE) in advance. Looking ahead, Bayer looks forward to joining hands with China to embrace more fruitful and prosperous years, driving continuous innovation and high-quality development in the healthcare and agricultural science sectors, and making greater contributions to helping the Chinese people lead healthier and better lives.